Catalyst Nurolight

在英国，45%的阿尔茨海默氏症患者患有睡眠障碍，这对他们的生活质量产生了负面影响。睡眠不好会加重记忆丧失、认知能力下降等症状，并加剧激动和攻击等行为。睡眠障碍也会对他们的护理伙伴产生负面影响，导致压力增加，抑郁和倦怠。当阿尔茨海默氏症患者和伴侣的睡眠受到影响时，留在家里变得更具挑战性，睡眠中断被认为是阿尔茨海默氏症患者比必要时更早接受护理的重要因素。研究表明，光疗法可以改善睡眠，减少轻度阿尔茨海默氏症的睡眠中断。在家庭环境中进行的光疗法研究也证明了对护理伙伴的益处，例如改善睡眠时间和睡眠/觉醒周期。我们提出了一种新技术（“NuroLight”），该技术使用现成的产品，基于证据的研究和智能技术提供光疗。这旨在改善阿尔茨海默氏症患者及其伴侣的生活质量，减少护理伴侣的倦怠，并随后减少早期入院护理阿尔茨海默氏症患者。随着越来越多的老年痴呆症患者生活在社区中，公共支出面临压力，支持人们在家中过上好日子是一个优先事项。

In the UK 45% of people with Alzheimer's experience sleep disturbances which negatively impact their quality of life. Poor sleep can compound symptoms such as memory loss, cognitive decline, and exacerbate behaviours such as agitation and aggression. Sleep disturbance can also negatively impact their care partners resulting in increased stress, depression, and burnout. When the sleep of both people with Alzheimer's and partners is affected, remaining at home becomes more challenging and sleep disruption has been attributed as a significant contributing factor to people with Alzheimer's being admitted into care earlier than necessary. Research demonstrates that light therapy can improve sleep and reduce sleep disruption in mild Alzheimer's. Light therapy research undertaken in the home environment has also demonstrated benefits to care partners such as improved sleep duration and sleep/wake cycle. We propose a new technology ('NuroLight') which offers light therapy, using off-the-shelf products, evidence-based research and smart technology. This aims to improve the quality of life for both the person with Alzheimer's and their partner, reduce care partner burnout, and subsequently reduce early admittance to care for the person with Alzheimer's. With more people with Alzheimer's living in the community and public spending under pressure, supporting people to live well at home is a priority.